DGX Filing
4Filing Date: Jun 2, 2026
QUEST DIAGNOSTICS INC (DGX) · Insider Trading (Form 4) SEC Filing
Statement of Changes in Beneficial Ownership
descriptionView SEC Filing
ACC: 0001599837-26-000005open_in_new
Total Value$1.94M
Trades1
Insiders1
Transaction Details
Davis J. E.
CEO and President, Director·Direct
Sell · Dispose
Common Stock
Shares-10.00K
Price$194.14
Total Value$1.94M
Shares Owned After132.42K
Transaction DateJun 1, 2026
10b5-1
Footnotes ▸
The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person.
Post-Transaction Holdings
Davis J. E.
| Security | Shares | Change |
|---|---|---|
| Common Stock | 132.42K | -10.00K (-7.02%) |
Original SEC Filing Textexpand_more
=== SEC Form 4 — Statement of Changes in Beneficial Ownership ===
Document Type: 4
Period of Report: 2026-06-01
10b5-1 Pre-arranged Plan: Yes
--- Issuer ---
Name: QUEST DIAGNOSTICS INC (DGX)
CIK: 0001022079
--- Reporting Owner ---
Name: Davis J. E.
CIK: 0001599837
Role: Director, Officer (CEO and President)
--- Non-Derivative Transactions ---
[Transaction #1]
Security: Common Stock
Date: 2026-06-01 | Code: S (Open market sale)
Shares: -10,000 | Price: $194.14
Total Value: $1,941,400.00
Shares Owned After: 132,423 | Ownership: D (Direct)
Footnotes:
[F1] The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person.
--- Footnotes (Complete Index) ---
F1: The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person.
--- Signature ---
/s/ Sean D. Mersten, Attorney in Fact for James E. Davis (2026-06-02)